Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
NCT00411151
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Barrett Esophagus
Interventions
DRUG:
Sunitinib-Malate
Sponsor
Johannes Gutenberg University Mainz
Collaborators
[object Object]